Spread the love
February 25, 2020
Treventis attends 8th Neurodegenerative Drug Development Summit
Treventis CSO Mark Reed was in attendance at the 8th Neurodegenerative Drug Development Summit (previously known as World CNS) held...
Read More
February 12, 2020
Treventis Attends Tau2020 Conference
Treventis VP Research Marcia Taylor has attended Tau2020 in Washington, DC, which is one of the world’s biggest conferences focusing...
Read More
December 13, 2019
Treventis founders publish new computational methodology for brain drug design
Treventis founders Dr. Donald Weaver, Mark Reed, and Christopher Barden have supervised research at Toronto hospital UHN into new methods...
Read More
November 6, 2019
Treventis attends BioPort Atlantic Conference
Treventis CEO Christopher Barden attended BioPort, Atlantic Canada’s largest health and life sciences event in Halifax, Nova Scotia. BioPort is...
Read More
November 6, 2019
Treventis gives invites presentation at Texas Life Science Forum
Treventis CSO Mark Reed attended the Texas Life Science Forum on November 7th in Houston, Texas, an event that brought...
Read More
October 27, 2019
Treventis attends the 2nd Neuromuscular Drug Development Summit (NMD)
CEO Christopher Barden attended the NMD Summit in Boston, Massachusetts, where he spoke with therapeutic and diagnostic companies that are...
Read More
October 24, 2019
Treventis scientists visit Society for Neuroscience conference
Treventis was represented at the 50th Society for Neuroscience Conference in Chicago, Illinois, one of the world’s largest conferences dedicated...
Read More
September 18, 2019
Treventis CEO invited speaker, panelist at XV International Pharma Licensing Symposium
Treventis CEO Christopher Barden was honored to be an invited speaker at the XV International Pharma Licensing Symposium, running from...
Read More
September 18, 2019
Treventis attends 4th Zebrafish for Personalized & Precision Medicine Conference
Treventis was represented at the 4th Zebrafish for Personalized & Precision Medicine Conference, running from Sep 18-20, 2019, in Toronto,...
Read More
July 14, 2019
Treventis founders present research at AAIC 2019
Treventis was well represented at the Alzheimer Association International Conference, running from Jul 14-18, 2019, in Los Angeles, California. In...
Read More